In focus
Latest feed
Pharma's Next Leap: Novo Nordisk and OpenAI Forge AI Alliance
GLP-1 Drugs: The Unexpected Battle Against Addiction
Eli Lilly's Retatrutide Triumphs in Key Diabetes Trial, Poised to Reshape Obesity Treatment Landscape
The Weight-Loss Revolution: Telehealth Giant Hims & Hers Dives into the GLP-1 Market
